LAURABOVERLAURA BOVER9005BOVER, LAURAAssociate Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson1901 East RoadHouston77054-3005TXAuthorship 1666371Authorship 1675791Authorship 1683143Authorship 1779954Authorship 18299378832108Ledda MF, Adris S, Bravo AI, Bover L, Carbone C, Paleolog E, Mordoh J, Chernajovsky Y, Podhajcer OLCellular and molecular biology (Noisy-le-Grand, France)Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model. Cell Mol Biol (Noisy-le-grand). 1996 Jul; 42(5):769-78.Cell Mol Biol (Noisy-le-grand)1996-07-01T00:00:001996Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.8832109Morvillo V, Bover L, Mordoh JCellular and molecular biology (Noisy-le-Grand, France)Identification and characterization of a 14 kDa immunosuppressive protein derived from IIB-MEL-J, a human melanoma cell line. Cell Mol Biol (Noisy-le-grand). 1996 Jul; 42(5):779-95.Cell Mol Biol (Noisy-le-grand)1996-07-01T00:00:001996Identification and characterization of a 14 kDa immunosuppressive protein derived from IIB-MEL-J, a human melanoma cell line.10414463Capurro M, Ballar? C, Bover L, Portela P, Mordoh JCancer immunology, immunotherapy : CIIDifferential lytic and agglutinating activity of the anti-Lewis(x) monoclonal antibody FC-2.15 on human polymorphonuclear neutrophils and MCF-7 breast tumor cells. In vitro and ex vivo studies. Cancer Immunol Immunother. 1999 May-Jun; 48(2-3):100-8.Cancer Immunol Immunother1999-05-01T00:00:001999Differential lytic and agglutinating activity of the anti-Lewis(x) monoclonal antibody FC-2.15 on human polymorphonuclear neutrophils and MCF-7 breast tumor cells. In vitro and ex vivo studies.16735691Cao W, Rosen DB, Ito T, Bover L, Bao M, Watanabe G, Yao Z, Zhang L, Lanier LL, Liu YJThe Journal of experimental medicinePlasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production. J Exp Med. 2006 Jun 12; 203(6):1399-405.J Exp Med2006-05-30T00:00:002006Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptor-induced interferon production.Cancer Systems ImagingGenomic MedicineGynecological Oncology & Reproductive MedicineLeukemiaLymphoma-MyelomaMelanoma Medical OncologyMolecular & Cellular OncologyMD AndersonMIEN-CHIEHUNGMIEN-CHIE HUNG8427HUNG, MIEN-CHIEProfessorJAMES PALLISONJAMES P ALLISON8659ALLISON, JAMES PProfessor0.7830350.00239269338research areas0.5180560.017662939coauthor of26.74174.5980860similar to1158selected publicationsHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorSATTVA SNEELAPUSATTVA S NEELAPU9154NEELAPU, SATTVA SAssociate ProfessorFULIANGCHUFULIANG CHU9532CHU, FULIANGInstructorANIL KSOODANIL K SOOD9048SOOD, ANIL KProfessorFLORIANMULLERFLORIAN MULLER9794MULLER, FLORIANAssistant ProfessorAuthorship 2142623Authorship 2228772Authorship 2250424Authorship 2278602Authorship 2278656Authorship 2320675Authorship 23516686587345Cabral S, Leis S, Bover L, Nembrot M, Mordoh JProceedings of the National Academy of Sciences of the United States of AmericaDipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells. Proc Natl Acad Sci U S A. 1984 May; 81(10):3200-3.Proc Natl Acad Sci U S A1984-05-01T00:00:001984Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells.16397212Kolonin MG, Bover L, Sun J, Zurita AJ, Do KA, Lahdenranta J, Card?-Vila M, Giordano RJ, Jaalouk DE, Ozawa MG, Moya CA, Souza GR, Staquicini FI, Kunyiasu A, Scudiero DA, Holbeck SL, Sausville EA, Arap W, Pasqualini RCancer researchLigand-directed surface profiling of human cancer cells with combinatorial peptide libraries. Cancer Res. 2006 Jan 01; 66(1):34-40.Cancer Res2006-01-01T00:00:002006Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries.17850179Cao W, Zhang L, Rosen DB, Bover L, Watanabe G, Bao M, Lanier LL, Liu YJPLoS biologyBDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells. PLoS Biol. 2007 Sep 11; 5(10):e248.PLoS Biol2007-09-11T00:00:002007BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells.18513999Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L, Qin FX, Gilliet M, Liu YJImmunityTwo functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity. 2008 Jun; 28(6):870-80.Immunity2008-05-29T00:00:002008Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.20193018Cao W, Bover LImmunological reviewsSignaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells. Immunol Rev. 2010 Mar; 234(1):163-76.Immunol Rev2010-03-01T00:00:002010Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells.22706086Bao M, Hanabuchi S, Facchinetti V, Du Q, Bover L, Plumas J, Chaperot L, Cao W, Qin J, Sun SC, Liu YJJournal of immunology (Baltimore, Md. : 1950)CD2AP/SHIP1 complex positively regulates plasmacytoid dendritic cell receptor signaling by inhibiting the E3 ubiquitin ligase Cbl. J Immunol. 2012 Jul 15; 189(2):786-92.J Immunol2012-06-15T00:00:002012CD2AP/SHIP1 complex positively regulates plasmacytoid dendritic cell receptor signaling by inhibiting the E3 ubiquitin ligase Cbl.24771328Voo KS, Foglietta M, Percivalle E, Chu F, Nattamai D, Harline M, Lee ST, Bover L, Lin HY, Baladandayuthapani V, Delgado D, Luong A, Davis RE, Kwak LW, Liu YJ, Neelapu SSInternational journal of cancerSelective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma. Int J Cancer. 2014 Dec 15; 135(12):2834-46.Int J Cancer2014-05-12T00:00:002014Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.Authorship 2361881Authorship 2363222Authorship 2368315Authorship 2370702Authorship 2371795Authorship 2386706Authorship 2387754Authorship 2388965Authorship 2390442Authorship 2398341Authorship 2400621Authorship 2413762Authorship 2472492Authorship 2500561Authorship 2523062Authorship 2567336Authorship 26070121661624Bover L, Barrio M, Slavutsky I, Bravo AI, Quintans C, Bagnati A, Lema B, Schiaffi J, Yomha R, Mordoh JBreast cancer research and treatmentDescription of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor. Breast Cancer Res Treat. 1991 Sep; 19(1):47-56.Breast Cancer Res Treat1991-09-01T00:00:001991Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor.2328778Guerra L, Bover L, Mordoh JExperimental cell researchDifferentiating effect of L-tyrosine on the human melanoma cell line IIB-MEL-J. Exp Cell Res. 1990 May; 188(1):61-5.Exp Cell Res1990-05-01T00:00:001990Differentiating effect of L-tyrosine on the human melanoma cell line IIB-MEL-J.2823256Resnicoff M, Medrano EE, Podhajcer OL, Bravo AI, Bover L, Mordoh JProceedings of the National Academy of Sciences of the United States of AmericaSubpopulations of MCF7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer. Proc Natl Acad Sci U S A. 1987 Oct; 84(20):7295-9.Proc Natl Acad Sci U S A1987-10-01T00:00:001987Subpopulations of MCF7 cells separated by Percoll gradient centrifugation: a model to analyze the heterogeneity of human breast cancer.3169151Podhajcer OL, Resnicoff M, Bover L, Medrano EE, Slavutsky I, Larripa I, Mordoh JExperimental cell researchEffect of estradiol and tamoxifen on the anchorage-independent growth of the subpopulations derived from MCF-7 breast carcinoma cells: cytogenetic analysis of the stem cell subpopulation. Exp Cell Res. 1988 Nov; 179(1):58-64.Exp Cell Res1988-11-01T00:00:001988Effect of estradiol and tamoxifen on the anchorage-independent growth of the subpopulations derived from MCF-7 breast carcinoma cells: cytogenetic analysis of the stem cell subpopulation.3281743Podhajcer OL, Bravo AI, Dain L, Guman N, Bover L, Mordoh JCancerIn vitro analysis of the cellular proliferative response to 17-beta-estradiol of human breast cancer. Cancer. 1988 May 01; 61(9):1807-12.Cancer1988-05-01T00:00:001988In vitro analysis of the cellular proliferative response to 17-beta-estradiol of human breast cancer.7567787Kairiyama C, Slavutsky I, Larripa I, Morvillo V, Bravo AI, Bover L, Podhajcer OL, Mordoh JPigment cell researchBiologic, immunocytochemical, and cytogenetic characterization of two new human melanoma cell lines: IIB-MEL-LES and IIB-MEL-IAN. Pigment Cell Res. 1995 Jun; 8(3):121-31.Pigment Cell Res1995-06-01T00:00:001995Biologic, immunocytochemical, and cytogenetic characterization of two new human melanoma cell lines: IIB-MEL-LES and IIB-MEL-IAN.7860998Podhajcer OL, Bover L, Bravo AI, Ledda MF, Kairiyama C, Calb I, Guerra L, Capony F, Mordoh JThe Journal of investigative dermatologyExpression of cathepsin D in primary and metastatic human melanoma and dysplastic nevi. J Invest Dermatol. 1995 Mar; 104(3):340-4.J Invest Dermatol1995-03-01T00:00:001995Expression of cathepsin D in primary and metastatic human melanoma and dysplastic nevi.8734932Ledda MF, Adris S, Bover L, Bravo AL, Mordoh J, Podhajcer OLMedicina[The role of SPARC gene in tumorigenic capacity of human melanoma cells]. Medicina (B Aires). 1996; 56(1):51-4.Medicina (B Aires)1996-01-01T00:00:001996[The role of SPARC gene in tumorigenic capacity of human melanoma cells].9008236Ledda F, Bravo AI, Adris S, Bover L, Mordoh J, Podhajcer OLThe Journal of investigative dermatologyThe expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J Invest Dermatol. 1997 Feb; 108(2):210-4.J Invest Dermatol1997-02-01T00:00:001997The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.9018235Ledda MF, Adris S, Bravo AI, Kairiyama C, Bover L, Chernajovsky Y, Mordoh J, Podhajcer OLNature medicineSuppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat Med. 1997 Feb; 3(2):171-6.Nat Med1997-02-01T00:00:001997Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells.9490204Capurro M, Bover L, Portela P, Livingston P, Mordoh JCancer immunology, immunotherapy : CIIFC-2.15, a monoclonal antibody active against human breast cancer, specifically recognizes Lewis(x) hapten. Cancer Immunol Immunother. 1998 Feb; 45(6):334-9.Cancer Immunol Immunother1998-02-01T00:00:001998FC-2.15, a monoclonal antibody active against human breast cancer, specifically recognizes Lewis(x) hapten.9674264Mordoh J, Kairiyama C, Bover L, Solarolo EMedicinaAllogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study. Medicina (B Aires). 1997; 57(4):421-7.Medicina (B Aires)1997-01-01T00:00:001997Allogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study.15130945Mantegazza AR, Barrio MM, Moutel S, Bover L, Weck M, Brossart P, Teillaud JL, Mordoh JBloodCD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells. Blood. 2004 Aug 15; 104(4):1183-90.Blood2004-05-06T00:00:002004CD63 tetraspanin slows down cell migration and translocates to the endosomal-lysosomal-MIICs route after extracellular stimuli in human immature dendritic cells.17548657Bover LC, Card?-Vila M, Kuniyasu A, Sun J, Rangel R, Takeya M, Aggarwal BB, Arap W, Pasqualini RJournal of immunology (Baltimore, Md. : 1950)A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. J Immunol. 2007 Jun 15; 178(12):8183-94.J Immunol2007-06-15T00:00:002007A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.19564354Cao W, Bover L, Cho M, Wen X, Hanabuchi S, Bao M, Rosen DB, Wang YH, Shaw JL, Du Q, Li C, Arai N, Yao Z, Lanier LL, Liu YJThe Journal of experimental medicineRegulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J Exp Med. 2009 Jul 06; 206(7):1603-14.J Exp Med2009-06-29T00:00:002009Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction.22453241Talukder AH, Bao M, Kim TW, Facchinetti V, Hanabuchi S, Bover L, Zal T, Liu YJCell researchPhospholipid scramblase 1 regulates Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Cell Res. 2012 Jul; 22(7):1129-39.Cell Res2012-03-27T00:00:002012Phospholipid scramblase 1 regulates Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells.24014877Voo KS, Bover L, Harline ML, Vien LT, Facchinetti V, Arima K, Kwak LW, Liu YJJournal of immunology (Baltimore, Md. : 1950)Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function. J Immunol. 2013 Oct 01; 191(7):3641-50.J Immunol2013-09-06T00:00:002013Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function.Authorship 2637648Authorship 2638548Authorship 27004777829891Mordoh J, Leis S, Bravo AI, Podhajcer OL, Ballare C, Capurro M, Kairiyama C, Bover LThe International journal of biological markersDescription of a new monoclonal antibody, FC-2.15, reactive with human breast cancer and other human neoplasias. Int J Biol Markers. 1994 Jul-Sep; 9(3):125-34.Int J Biol Markers1994-07-01T00:00:001994Description of a new monoclonal antibody, FC-2.15, reactive with human breast cancer and other human neoplasias.9620446Bover L, Barrio M, Bravo AI, Slavutsky I, Larripa I, Bolondi A, Ayala M, Mordoh JCellular and molecular biology (Noisy-le-Grand, France)The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo. Cell Mol Biol (Noisy-le-grand). 1998 May; 44(3):493-504.Cell Mol Biol (Noisy-le-grand)1998-05-01T00:00:001998The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo.20696886Kim T, Pazhoor S, Bao M, Zhang Z, Hanabuchi S, Facchinetti V, Bover L, Plumas J, Chaperot L, Qin J, Liu YJProceedings of the National Academy of Sciences of the United States of AmericaAspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells. Proc Natl Acad Sci U S A. 2010 Aug 24; 107(34):15181-6.Proc Natl Acad Sci U S A2010-08-09T00:00:002010Aspartate-glutamate-alanine-histidine box motif (DEAH)/RNA helicase A helicases sense microbial DNA in human plasmacytoid dendritic cells.Authorship 27444214Authorship 275584221339324Pedroza-Gonzalez A, Xu K, Wu TC, Aspord C, Tindle S, Marches F, Gallegos M, Burton EC, Savino D, Hori T, Tanaka Y, Zurawski S, Zurawski G, Bover L, Liu YJ, Banchereau J, Palucka AKThe Journal of experimental medicineThymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med. 2011 Mar 14; 208(3):479-90.J Exp Med2011-02-21T00:00:002011Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation.24928999Voo KS, Bover L, Harline ML, Weng J, Sugimoto N, Liu YJJournal of immunology (Baltimore, Md. : 1950)Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells. J Immunol. 2014 Jul 15; 193(2):627-34.J Immunol2014-06-13T00:00:002014Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells.Authorship 2888674Authorship 2947954Authorship 2951223Authorship 303361324495546Hu J, Vien LT, Xia X, Bover L, Li SBiological procedures onlineGeneration of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells. Biol Proced Online. 2014 Feb 04; 16(1):3.Biol Proced Online2014-02-04T00:00:002014Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells.25646014Arumugam T, Deng D, Bover L, Wang H, Logsdon CD, Ramachandran VMolecular cancer therapeuticsNew Blocking Antibodies against Novel AGR2-C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in Mice. Mol Cancer Ther. 2015 Apr; 14(4):941-51.Mol Cancer Ther2015-02-02T00:00:002015New Blocking Antibodies against Novel AGR2-C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in Mice.25779950Karjalainen K, Jaalouk DE, Bueso-Ramos C, Bover L, Sun Y, Kuniyasu A, Driessen WH, Card?-Vila M, Rietz C, Zurita AJ, O'Brien S, Kantarjian HM, Cortes JE, Calin GA, Koivunen E, Arap W, Pasqualini RClinical cancer research : an official journal of the American Association for Cancer ResearchTargeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens. Clin Cancer Res. 2015 Jul 01; 21(13):3041-51.Clin Cancer Res2015-03-16T00:00:002015Targeting IL11 Receptor in Leukemia and Lymphoma: A Functional Ligand-Directed Study and Hematopathology Analysis of Patient-Derived Specimens.25950475Puebla-Osorio N, Damiani E, Bover L, Ullrich SECell death & diseasePlatelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells. Cell Death Dis. 2015 May 07; 6:e1745.Cell Death Dis2015-05-07T00:00:002015Platelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells.74Professor10Assistant Professor54Instructor14Associate ProfessorMANISHASINGHMANISHA SINGH11811SINGH, MANISHAInstructorAuthorship 842635Authorship 848280Authorship 851440Authorship 860438Authorship 861292Authorship 862062Authorship 866477Cell Death and DiseasePlatelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells. Cell Death and Disease. 6.Platelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cellsJournal of Radioanalytical and Nuclear ChemistryTumor imaging with <sup>99m</sup>Tc-labeled FC-5.01 monoclonal antibody using a single step labeling method. Journal of Radioanalytical and Nuclear Chemistry. 245:337-341.Tumor imaging with <sup>99m</sup>Tc-labeled FC-5.01 monoclonal antibody using a single step labeling methodInmunologiaBiological aspects of human plasmacytoid dendritic cells and their leukemic counterparts; similarities and differences. Inmunologia. 29:125-134.Biological aspects of human plasmacytoid dendritic cells and their leukemic counterparts; similarities and differencesMolecular Cancer TherapeuticsNew blocking antibodies against novel AGR2-C4.4A pathway reduce growth and metastasis of pancreatic tumors and increase survival in mice. Molecular Cancer Therapeutics. 14:941-951.New blocking antibodies against novel AGR2-C4.4A pathway reduce growth and metastasis of pancreatic tumors and increase survival in miceClinical Cancer ResearchTargeting IL11 receptor in leukemia and lymphoma. Clinical Cancer Research. 21:3041-3051.Targeting IL11 receptor in leukemia and lymphomaJournal of Experimental and Clinical Cancer ResearchAnalysis of DNA synthesis and carcinoembryonic antigen expression in human breast cancer. Journal of Experimental and Clinical Cancer Research. 7:35-42.Analysis of DNA synthesis and carcinoembryonic antigen expression in human breast cancerBiological Procedures OnlineGeneration of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells. Biological Procedures Online. 16.Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells28566332Jiang H, Rivera-Molina Y, Gomez-Manzano C, Clise-Dwyer K, Bover L, Vence LM, Yuan Y, Lang FF, Toniatti C, Hossain MB, Fueyo JCancer researchOncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination. Cancer Res. 2017 07 15; 77(14):3894-3907.Cancer Res2017-05-31T00:00:002017Oncolytic Adenovirus and Tumor-Targeting Immune Modulatory Therapy Improve Autologous Cancer Vaccination.19273860Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu YJProceedings of the National Academy of Sciences of the United States of AmericaIdentification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci U S A. 2009 Mar 24; 106(12):4793-8.Proc Natl Acad Sci U S A2009-03-09T00:00:002009Identification of IL-17-producing FOXP3+ regulatory T cells in humans.Authorship 8899325D003713Anatomy36310770.617448Dendritic CellsD000911Chemicals & Drugs99043510.391324Antibodies, MonoclonalD011971Chemicals & Drugs2023100.851591Receptors, ImmunologicD001402Anatomy47412920.636066B-LymphocytesAuthorship 92498511Authorship 933454329180606Qin H, Wei G, Sakamaki I, Dong Z, Cheng WA, Smith DL, Wen F, Sun H, Kim K, Cha S, Bover L, Neelapu SS, Kwak LWClinical cancer research : an official journal of the American Association for Cancer ResearchNovel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo. Clin Cancer Res. 2018 03 01; 24(5):1114-1123.Clin Cancer Res2017-11-27T00:00:002017Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo.30277474Bi E, Li R, Bover LC, Li H, Su P, Ma X, Huang C, Wang Q, Liu L, Yang M, Lin Z, Qian J, Fu W, Liu YJ, Yi QThe Journal of clinical investigationE-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs. J Clin Invest. 2018 11 01; 128(11):4821-4831.J Clin Invest2018-10-02T00:00:002018E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs.D015703Chemicals & Drugs56113810.672956Antigens, CDImmunologyDepartment of RadiologyRadiologyBaylor College of MedicineJAMESCROWEJAMES CROWE0.000000000000000.000000000000001560CROWE, JAMESAssociate ProfessorAuthorship 952444631332047Yeung TL, Leung CS, Yip KP, Sheng J, Vien L, Bover LC, Birrer MJ, Wong STC, Mok SCClinical cancer research : an official journal of the American Association for Cancer ResearchAnticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer. Clin Cancer Res. 2019 11 01; 25(21):6417-6428.Clin Cancer Res2019-07-22T00:00:002019Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer.true1Associate ProfessorAssociate ProfessorAuthorship 994295332658853McAllister F, Mantegazza A, Garz?n F, Rotbaum V, Remondino G, Vazquez Larsson M, Geffner J, Rabinovich GA, Bover LMedicina[Use of convalescent plasma for COVID-19 treatment. History and evidence]. Medicina (B Aires). 2020; 80 Suppl 3:82-86.Medicina (B Aires)2020-01-01T00:00:002020[Use of convalescent plasma for COVID-19 treatment. History and evidence].Authorship 1029211234486917Wilson NR, Bover L, Konopleva M, Han L, Neelapu S, Pemmaraju NLeukemia & lymphomaCD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies. Leuk Lymphoma. 2022 01; 63(1):19-30.Leuk Lymphoma2021-09-06T00:00:002021CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies.Authorship 1036754434993940Muhsin A, Rangel R, Vien L, Bover LMethods in molecular biology (Clifton, N.J.)Monoclonal Antibodies Generation: Updates and Protocols on Hybridoma Technology. Methods Mol Biol. 2022; 2435:73-93.Methods Mol Biol2022-01-01T00:00:002022Monoclonal Antibodies Generation: Updates and Protocols on Hybridoma Technology.Authorship 1038272835283189Yang R, Sun L, Li CF, Wang YH, Xia W, Liu B, Chu YY, Bover L, Vien L, Hung MCThe Journal of biological chemistryDevelopment and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death. J Biol Chem. 2022 04; 298(4):101821.J Biol Chem2022-03-11T00:00:002022Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death.Authorship 10488741135720386Singh S, Roszik J, Saini N, Singh VK, Bavisi K, Wang Z, Vien LT, Yang Z, Kundu S, Davis RE, Bover L, Diab A, Neelapu SS, Overwijk WW, Rai K, Singh MFrontiers in immunologyB Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade. Front Immunol. 2022; 13:794684.Front Immunol2022-05-26T00:00:002022B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade.Authorship 105993628Authorship 1056995436175679Li Y, Basar R, Wang G, Liu E, Moyes JS, Li L, Kerbauy LN, Uprety N, Fathi M, Rezvan A, Banerjee PP, Muniz-Feliciano L, Laskowski TJ, Ensley E, Daher M, Shanley M, Mendt M, Acharya S, Liu B, Biederst?dt A, Rafei H, Guo X, Melo Garcia L, Lin P, Ang S, Marin D, Chen K, Bover L, Champlin RE, Varadarajan N, Shpall EJ, Rezvani KNature medicineKIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape. Nat Med. 2022 Oct; 28(10):2133-2144.Nat Med2022-09-29T00:00:002022KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape.36139163Khadka S, Vien L, Leonard P, Bover L, Muller FBiomoleculesGeneration and Validation of an Anti-Human PANK3 Mouse Monoclonal Antibody. Biomolecules. 2022 09 19; 12(9).Biomolecules2022-09-19T00:00:002022Generation and Validation of an Anti-Human PANK3 Mouse Monoclonal Antibody.Authorship 10838241138007239Chu F, Cao J, Liu J, Yang H, Davis TJ, Kuang SQ, Cheng X, Zhang Z, Karri S, Vien LT, Bover L, Sun R, Vega F, Green M, Davis RE, Neelapu SSJournal for immunotherapy of cancerChimeric antigen receptor T cells to target CD79b in B-cell lymphomas. J Immunother Cancer. 2023 11 24; 11(11).J Immunother Cancer2023-11-24T00:00:002023Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas.Authorship 10863512838182787Li Y, Basar R, Wang G, Liu E, Moyes JS, Li L, Kerbauy LN, Uprety N, Fathi M, Rezvan A, Banerjee PP, Muniz-Feliciano L, Laskowski TJ, Ensley E, Daher M, Shanley M, Mendt M, Acharya S, Liu B, Biederst?dt A, Rafei H, Guo X, Melo Garcia L, Lin P, Ang S, Marin D, Chen K, Bover L, Champlin RE, Varadarajan N, Shpall EJ, Rezvani KNature medicineAuthor Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape. Nat Med. 2024 Mar; 30(3):906.Nat Med2024-03-01T00:00:002024Author Correction: KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape.true1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professortrue1InstructorInstructortrue1InstructorInstructor